Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |